BioSpace News Archive

Renowned oncology leader to head scientific innovation at Foundation Medicine

Precigen, Inc., a wholly-owned subsidiary of Intrexon Corporation (NASDAQ: XON) and a biopharmaceutical company specializing in the development of innovative gene and cellular therapies to improve the lives of patients, today announced that the first patient has been dosed with Precigen’s PRGN-3005, a first-in-class investigational therapy using Precigen’s UltraCAR-T™ therapeutic platform.

Company Appoints Seasoned Biotech Leaders to Oversee Legal, Corporate Strategy, Financial Planning, and Business Development and Alliance Management

The Company’s J-Plasma handpieces are indicated for cutting, coagulation and ablation of soft tissue during open and laparoscopic surgical procedures.

Squarex, a clinical-stage pharmaceutical company developing a topical immunomodulator for the long-term prevention of recurrent cold sores and other infections caused by herpes simplex viruses, today announced positive results from a Phase 2 study of its investigational compound SQX770

Australian patients with diabetes-induced eye disease can now access a new treatment option that provides consistent and continuous treatment with long-lasting effect.

In pursuit of better treatment options and cures for lung diseases, today the American Lung Association announces an investment of $6.45 million in promising research to fund an expected 64 grants for FY20.

Funding moves company closer to bringing affordable, accurate lab tests into consumer homes

Secure Exchange Solutions (SES) a leading provider of interoperable, cloud-based clinical data exchange and Artificial Intelligence (AI) powered technologies, was referenced by Gartner, the world’s leading research and advisory company, as a HIE vendor in its May 2019 report, The Current State of Clinical Data Integration Among U.S. Healthcare Payers.

The Pediatric Academic Societies (PAS) is pleased to announce Francis S. Collins, MD, PhD, as the keynote speaker at the PAS 2020 Meeting, taking place April 29 through May 6 in Philadelphia.